Monopar Therapeutics Inc.

• Monopar Therapeutics Inc Estimates – DUS:1IY0
  TradingView · 23 Oct 2026
• Form 4 Monopar Therapeutics Inc: Quan Anh Vu (CFO) For: 30 September
  Investing.com India · 13 Oct 2026
• Form 4 Monopar Therapeutics Inc For: 11 October By Investing.com
  Investing.com Nigeria · 12 Oct 2026
• Monopar Therapeutics director Christopher Starr sells shares worth $659k
  Investing.com · 11 Oct 2026
• Form 4 Monopar Therapeutics Inc For: 6 October By Investing.com
  Investing.com Nigeria · 06 Oct 2026
• Monopar Therapeutics director Starr sells $659,386 in stock
  Investing.com · 06 Oct 2026
• Form 144 MONOPAR THERAPEUTICS INC For: 1 October By Investing.com
  Investing.com UK · 01 Oct 2026
• Form 4 insider transaction filed pressures Monopar Therapeutics stock below $74.23 support
  Traders Union · 29 Sep 2026
• Form 4 Monopar Therapeutics Inc For: 28 September By Investing.com
  Investing.com UK · 29 Sep 2026
• Monopar Therapeutics CEO Robinson sells $2.5m in stock
  Investing.com · 28 Sep 2026
• Monopar Therapeutics stock price prediction: Support pressure looms at $81.33
  Traders Union · 25 Sep 2026
• Stock-option shares are proposed for sale by Chandler Robinson at Monopar Therapeutics (NASDAQ: MNPR).
  Stock Titan · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →